Clinical Trials Browser

Phase 1/2 × INDUSTRY × Advanced Tumors × Clear all

NCT07110584 2026-03-05

Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

Phase 1/2 Recruiting

Advanced Tumors

NCT02419417 2022-06-16

BET

Phase 1/2 Completed

83 enrolled 47 charts

Advanced Tumors